Medical Weight-Loss Programme
Support your weight-loss journey through a clinically supervised programme combining prescription-based treatment, including Mounjaro, with supportive IV therapy. This programme combines medically prescribed Mounjaro therapy with a targeted Weight-Loss Support IV infusion to help support the body throughout treatment. As the medication works to regulate appetite and metabolic pathways, the IV infusion helps maintain hydration, nutrient balance, and energy levels. This integrated approach supports overall physiological stability during a structured, clinician-guided weight-management programme.
-
Clinician-led, prescription-based support combining IV therapy and medical weight management.
-
Medical assessment required • Individualised dosage options
Programme Overview
These IV infusions are designed to compliment medically supervised weight-management treatment by supporting hydration, nutrient balance, and energy levels throughout the programme. Medications such as Mounjaro can place additional metabolic demands on the body, particularly during the early stages of treatment or when doses increase. The inclusion of a targeted Weight-Loss Support IV helps replenish essential vitamins, amino acids, and micronutrients that support energy production and metabolic balance during therapy. By delivering these nutrients directly into the bloodstream for optimal absorption, the infusion helps patients maintain strength and wellbeing while progressing through the structured treatment plan. All treatments are delivered under clinical oversight as part of a carefully monitored weight-management programme.
How the Programme Works
Stage One
A medical evaluation is conducted to determine suitability for prescription-based weight management, including the use of Mounjaro, and to assess overall health status.
Clinical Consultation and Assessment
Stage Two
An appropriate treatment plan is prescribed, which may include Mounjaro in combination with supportive IV therapy, based on clinical findings and individual patient needs.
Dosage Selection and Treatment Planning
Stage Three
Treatment response is monitored over time, with adjustments made under clinical guidance to ensure safety and suitability.
Ongoing Monitoring and Adjustment
Dosage Options
Dosage selection is guided by clinical assessment and treatment response. The following dosage options are available as part of the programme:
View dosage details to learn more about each option.
Each dosage option has its own plan details, duration options, and checkout process, determined as part of a clinically guided treatment pathway.
Best Value Programme
9-Month Metabolic Transformation Programme
A complete, clinician-guided treatment pathway designed to support sustained weight loss through structured Mounjaro dose escalation and monthly IV metabolic support.
Programme Structure
Each month includes four combined Mounjaro + Weight-Loss Support IV treatments, delivered weekly.
Over the full program, patients receive 36 treatments across 9 months, progressing through the 2.5 mg, 5 mg, and 7.5 mg dosage phases under clinical supervision.
2.5 mg Initiation Phase
Months 1–3
Introduces Mounjaro at a lower dose to allow the body to adapt to treatment while beginning metabolic and appetite regulation under clinical supervision.
Months 4–6
5 mg Progression Phase
The dosage is increased to maintain treatment effectiveness and support continued metabolic response as the body adjusts to therapy.
Months 7–9
7.5 mg Advanced Phase
A further increase in dosage helps sustain therapeutic impact and supports ongoing weight-management progress during the later stage of the programme.
12 Treatments delivered during this phase
12 Treatments delivered during this phase
12 Treatments delivered during this phase
Each monthly session includes a Weight-Loss Support IV infusion to help maintain hydration, nutrient balance, and energy levels throughout treatment.
Programme Price
R67 491.49
Who is this programme for?
Individuals requiring medical support for weight management
Patients for whom prescription-based treatment, including Mounjaro, may be clinically appropriate
Those who have not achieved sufficient results through lifestyle interventions alone
Clients seeking structured, clinician-guided weight management support
Important Considerations
-
This programme includes prescription-based medical treatment, including Mounjaro
-
Medical suitability is assessed prior to initiation. Not appropriate for all individuals
-
Ongoing clinical oversight is required throughout the programme
-
Treatment is not a substitute for medical care and forms part of a broader health management approach